IN2013MU02582A - - Google Patents

Info

Publication number
IN2013MU02582A
IN2013MU02582A IN2582MU2013A IN2013MU02582A IN 2013MU02582 A IN2013MU02582 A IN 2013MU02582A IN 2582MU2013 A IN2582MU2013 A IN 2582MU2013A IN 2013MU02582 A IN2013MU02582 A IN 2013MU02582A
Authority
IN
India
Prior art keywords
tapentadol
salt
relates
present
orally disintegrating
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Yatendra
Swain Kapileswar
Suggala Vijay
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN2582MU2013 priority Critical patent/IN2013MU02582A/en
Publication of IN2013MU02582A publication Critical patent/IN2013MU02582A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2582MU2013 2013-08-05 2013-08-05 IN2013MU02582A (hr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2582MU2013 IN2013MU02582A (hr) 2013-08-05 2013-08-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2582MU2013 IN2013MU02582A (hr) 2013-08-05 2013-08-05

Publications (1)

Publication Number Publication Date
IN2013MU02582A true IN2013MU02582A (hr) 2015-06-12

Family

ID=54199326

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2582MU2013 IN2013MU02582A (hr) 2013-08-05 2013-08-05

Country Status (1)

Country Link
IN (1) IN2013MU02582A (hr)

Similar Documents

Publication Publication Date Title
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
PH12016501750A1 (en) Human plasma kallikrein inhibitors
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015502002A1 (en) Tripeptide epoxy ketone protease inhibitors
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
MX368903B (es) Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
IN2013MU03583A (hr)
PH12016502352A1 (en) Pharmaceutical composition
JO3326B1 (ar) مثبطات إيبوكسي كيتون بروتياز ثلاثي الببتيد
TW201613578A (en) Pharmaceutical combinations
MX2021010297A (es) Inhibidores de calicreina plasmatica humana.
DOP2013000314A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
MX2015007488A (es) Composicion farmaceutica oftalmologica topica que contiene regorafenib.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
IN2013MU02582A (hr)
IN2013MU02581A (hr)
IN2013MU03428A (hr)
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
MX2018013428A (es) Composicion farmaceutica de comprimido en comprimido que comprende ciclofosfamida y capecitabina.
UA81932U (ru) Комбинированный препарат "ротрин-дента" в виде геля для лечения воспалительных заболеваний слизистой оболочки полости рта
IN2013MU03639A (hr)